Most of the focus in generative AI has been on text-based interfaces used to generate text, images, and more. The next wave appears to be voice, and it’s ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close.

This upward trajectory reflects growing investor confidence in Vertex’s business model and future prospects. Another major growth driver is the increasing global adoption of e-invoicing mandates.

In a groundbreaking series of announcements at its GTC conference, NVIDIA on Tuesday unveiled a portfolio of AI-driven ...

Mistral Small 3.1, a 24B parameter AI marvel outshines industry giants like Gemma 3 and GPT-4o mini. Download Mistral Small 3 ...

Our 2024 results demonstrate the durability and consistency of Vertex’s business model. We lead in the enterprise space for indirect tax software because our 47-year heritage serving the ...

Anthropic is releasing Claude 3.7 Sonnet, its first “hybrid reasoning model” that can solve more complex problems and outperforms previous models in areas like math and coding.

Dubbed the “world’s best single-accelerator model” to date, Gemma 3 joins the Gemmaverse as Google’s latest open model to be ...

Optum Rx is cutting prior authorizations on 80 drugs and updating payment models to improve reimbursements, benefiting ...